Table 3.
Predictive models for outcome.
OR | 95% CI | p-Value | AUC | 95% CI | p-Value | |
---|---|---|---|---|---|---|
All XAI populations | 0.95 | 0.91–0.98 | <0.0001 | |||
CLL-IPI | 0.78 | 0.70–0.86 | <0.0001 | |||
Four-factor model | 0.84 | 0.77–0.91 | <0.0001 | |||
CLL-IPI | 1.53 | 1.19–2.04 | 0.0018 | |||
T1C0016 (CD4+ T cells) | 0.86 | 0.78–0.93 | 0.0003 | |||
T1C0023 (CD8+ T cells) | 1.14 | 0.95–1.77 | 0.3305 | |||
CD38 | 1.01 | 1.00–1.02 | 0.1790 | |||
Two-factor model with IPI | 0.83 | 0.77–0.90 | <0.0001 | |||
CLL-IPI | 1.64 | 1.29–2.16 | 0.0001 | |||
T1C0016 (CD4+ T cells) | 0.85 | 0.78–0.92 | 0.0002 | |||
Two-factor model w/o IPI | 0.79 | 0.71–0.87 | <0.0001 | |||
T1C0016 (CD4+ T cells) | 0.85 | 0.78–0.91 | <0.0001 | |||
T1C0023 (CD8+ T cells) | 1.29 | 1.05–2.14 | 0.1390 |
Abbreviations: OR = odds ratio; TTF = time to first-line treatment failure; AUC = area under curve; CI = confidence interval, IPI = International Prognostic Index.